Reaction
Cutaneous Leishmaniasis reporting signals
As of the last recalculation, Cutaneous Leishmaniasis appears in 249 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is ADALIMUMAB-FKJP (PRR 148.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Adalimumab-Fkjp | 62 | 148.6 | 148.8 |
| Adalimumab-Aaty | 62 | 145.5 | 145.7 |
| Adalimumab-Adaz | 62 | 130.4 | 130.6 |